Disease Diagnosis/Detection

  • Your Selections:

Refine Results

date

Tags

New Indian Lab To Test MDR-TB In 24 Hours At No Cost

A lab openned in India on Thursday at the Ahmedabad Civil Hospital that will reduce test times for drug-resistant strains of tuberculosis and offer tests for free, Indian Express reports. At the new lab, test results can be given within 24 hours, which could reduce TB mortality, Indian Express writes. The new lab is…

WHO Appeals For Donated, Low-Cost H1N1 Vaccines

The WHO’s flu chief Keiji Fukuda on Saturday called upon wealthy nations and vaccine manufacturers to donate H1N1 (swine) flu vaccines to developing countries, the Associated Press reports.

Recent Releases: Limiting Corruption; Mental Health; U.S. Global Health Policies; Non-Physician Administered ARV; African Health Ministers

Lancet Infectious Diseases Features Reflection On Use Of HIV/AIDS Money In Mozambique A Lancet Infectious Diseases Reflection and Reaction piece says while PEPFAR’s “investment of over US$228 million into Mozambique in 2008 alone” resulted in “an exponential increase in the number of people on” ARVs and boosted prevention programs, “[t]here is more money…

‘Explosion’ Of H1N1 Cases Likely In Coming Months, WHO Says

In the coming months, countries should prepare for an “explosion” in new cases of H1N1 (swine) flu until peak transmission of the virus is reached, the WHO’s Western Pacific director, Shin Young-soo told a symposium of health officials gathered in Beijing Friday, the Associated Press reports.

WHO Says Confirmed H1N1 Deaths Worldwide Reach 1,799

According to the latest WHO report out Wednesday, the number of confirmed H1N1 (swine) flu deaths since its emergence in April has reached 1,799 – a jump from 1,462 deaths since the agency’s last update, Agence France-Presse/the Australian reports.

Also In Global Health News: NTD Consortium; Clean Water Access; PEPFAR Lab Donation; River Blindness Elimination; Vaccines In India

European Laboratories Form Consortium To Study Neglected Tropical Diseases A handful of European universities and industries have formed a consortium to “boost drug development for the treatment of two deadly diseases, the African sleeping sickness and Leishmaniasis, which affect millions of people worldwide,” afrol News reports. “This new project combines…